Back to Authors

Master, Zubin

0000-0002-3462-4546

Mayo Clinic

Associate Professor, Biomedical Ethics Research Program & Center for Regenerative Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA.

Citations 17

Evaluating the FDA Regenerative Medicine Framework: Opportunities for Stakeholders
Akkas, Farzana, Master, Zubin , Master, Zubin , Richardson, Elizabeth

Regenerative Medicine | August 20, 2020 | Volume: 15 | Issue: 7 | Pages: 1825-1832

10.2217/rme-2020-0073 Get It

Challenging Misinformation and Engaging Patients: Characterizing a Regenerative Medicine Consult Service
Smith, Cambray , Martin-Lillie, Charlene , Higano, Jennifer Dens , Turner, Leigh , Phu, Sydney N. , Arthurs, Jennifer R. , Shapiro, Shane A. , Master, Zubin , Arthurs, Jennifer, Shapiro, Shane , Master, Zubin , Dens Higano, Jennifer , Nelson, Timothy J.

Regenerative Medicine | April 22, 2020 | Volume: 15 | Issue: 3 | Pages: 1427-1440

10.2217/rme-2020-0018 Get It

Survey of equal contributions in biomedical research publications
Resnik, David B. , Smith, Elise , Master, Zubin , Shi, Min , Master, Zubin

Accountability in Research | January 27, 2020 | Volume: 27 | Issue: 3 | Pages: 115-137

10.1080/08989621.2020.1722947 Get It

Fostering a prevention mindset for responsible gene editing
Meagher, Karen M. , Master, Zubin , Master, Zubin , Meagher, Karen M

Accountability in Research | May 10, 2019 | Volume: 26 | Issue: 4 | Pages: 251-256

10.1080/08989621.2019.1617140 Get It

Preparing Regenerative Therapies for Clinical Application: Proposals for Responsible Translation
Smith, Cambray , Arthurs, Jennifer R. , Master, Zubin , Smith, Cambray G, Master, Zubin , Shapiro, Shane A.

Regenerative Medicine | January 17, 2019 | Volume: 14 | Issue: 2 | Pages: 77-84

10.2217/rme-2018-0163 Get It

The stem cell market and policy options: a call for clarity
Zarzeczny, Amy , Illes, Judy , Master, Zubin , Robillard, Julie M. , Turner, Leigh , Zettler, Patricia J. , Master, Zubin , Atkins, Harold L. , Kimmelman, Jonathan , Snyder, Jeremy , Caulfield, Timothy

Journal of Law and the Biosciences | October 15, 2018 | Volume: 5 | Issue: 3 | Pages: 743-758

10.1093/jlb/lsy025 Get It

Industry Responsibilities in Tackling Direct‐to‐Consumer Marketing of Unproven Stem Cell Treatments
Master, Zubin , Fu, Wayne , Paciulli, Danielle, Sipp, Douglas , Master, Zubin

Clinical Pharmacology & Therapeutics | July 11, 2017 | Volume: 102 | Issue: 2 | Pages: 177-179

10.1002/cpt.704 Get It

The direct‐to‐consumer marketing of unproven stem cell interventions (SCIs) is a serious public health concern. Regulations and education have had modest impact, indicating that different actors must play a role to stop this unfettered market. We consider the role of the biotech industry in tackling unproven SCIs. Grounded in the concept of corporate social responsibility, we argue that biotech companies should screen consumers to ensure that products and services are being used appropriately and educate employees about unproven SCIs.